Standout Papers

Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients ... 2009 2026 2014 2020 581
  1. Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer (2009)
    David Cunningham, Ian Chau et al. Journal of Clinical Oncology

Immediate Impact

7 from Science/Nature 79 standout
Sub-graph 1 of 21

Citing Papers

Pancreatic cancer: Advances and challenges
2023 Standout
Neoadjuvant therapy for pancreatic cancer
2023 Standout
10 intermediate papers

Works of J. Ostrowski being referenced

Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
2009 Standout

Author Peers

Author Last Decade Papers Cites
J. Ostrowski 129 16 551 236 171 5 614
Karin Rita Tamas 96 14 482 206 158 5 542
H Schönekäs 219 28 532 218 246 11 676
Noël Stremsdoerfer 166 7 512 188 309 7 633
Jörg W. Sturm 260 39 561 149 198 11 701
Joseph T. Ruggiero 95 15 417 240 146 8 699
Carolin Reiser 238 15 573 134 191 7 731
Jörg Seraphin 160 25 576 260 230 7 615
M. López García 261 19 534 187 179 5 669
Catherine Chodkiewicz 75 27 385 108 267 10 636
Augusto J. Bastidas 151 8 399 317 119 7 660

All Works

Loading papers...

Rankless by CCL
2026